Nicole LaBrosse - Feb 15, 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF FINANCIAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 15, 2023
Transactions value $
-$30,553
Form type
4
Date filed
2/17/2023, 05:25 AM
Previous filing
Feb 14, 2023
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +1.25K +21.38% $0.00 7.12K Feb 15, 2023 Direct
transaction HALO Common Stock Tax liability -$30.6K -621 -8.72% $49.20 6.5K Feb 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -1.25K -33.33% $0.00 2.51K Feb 15, 2023 Common Stock 1.25K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 621 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F2 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.